Russell Investments Group Ltd. Has $217.75 Million Stake in Danaher Corporation (NYSE:DHR)

Key Points

• Russell Investments Group Ltd. increased its stake in Danaher Corporation by 11.4%, owning 1,061,970 shares valued at approximately $217.75 million.
• Danaher reported earnings of $1.80 per share, surpassing analyst expectations, with quarterly revenue of $5.94 billion and a net margin of 14.21%.
• Several analysts have recently adjusted price targets for Danaher, with the average target set at $247.61, while maintaining a consensus rating of "Moderate Buy."

Russell Investments Group Ltd. increased its position in Danaher Corporation (NYSE:DHR - Free Report) by 11.4% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,061,970 shares of the conglomerate's stock after acquiring an additional 108,696 shares during the quarter. Russell Investments Group Ltd. owned about 0.15% of Danaher worth $217,749,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Prudential PLC lifted its holdings in Danaher by 21.5% during the 1st quarter. Prudential PLC now owns 69,116 shares of the conglomerate's stock valued at $14,169,000 after purchasing an additional 12,241 shares during the last quarter. Resona Asset Management Co. Ltd. lifted its holdings in Danaher by 12.6% during the 1st quarter. Resona Asset Management Co. Ltd. now owns 441,455 shares of the conglomerate's stock valued at $90,588,000 after purchasing an additional 49,299 shares during the last quarter. Ballast Inc. raised its stake in shares of Danaher by 1.8% in the first quarter. Ballast Inc. now owns 5,343 shares of the conglomerate's stock worth $1,095,000 after acquiring an additional 93 shares during the last quarter. Independent Advisor Alliance lifted its position in shares of Danaher by 2.1% during the first quarter. Independent Advisor Alliance now owns 5,392 shares of the conglomerate's stock worth $1,105,000 after purchasing an additional 110 shares in the last quarter. Finally, Cove Private Wealth LLC lifted its position in shares of Danaher by 41.8% during the first quarter. Cove Private Wealth LLC now owns 2,836 shares of the conglomerate's stock worth $581,000 after purchasing an additional 836 shares in the last quarter. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Danaher Stock Performance

Shares of DHR traded up $0.62 during midday trading on Friday, reaching $210.84. The stock had a trading volume of 3,210,213 shares, compared to its average volume of 4,658,279. The firm has a 50 day simple moving average of $199.94 and a 200-day simple moving average of $199.87. Danaher Corporation has a one year low of $171.00 and a one year high of $279.90. The firm has a market cap of $150.97 billion, a PE ratio of 44.86, a P/E/G ratio of 2.93 and a beta of 0.73. The company has a current ratio of 1.62, a quick ratio of 1.22 and a debt-to-equity ratio of 0.32.

Danaher (NYSE:DHR - Get Free Report) last posted its earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.64 by $0.16. The company had revenue of $5.94 billion during the quarter, compared to analysts' expectations of $5.83 billion. Danaher had a net margin of 14.21% and a return on equity of 10.70%. Danaher's quarterly revenue was up 3.4% compared to the same quarter last year. During the same quarter last year, the company posted $1.72 EPS. As a group, sell-side analysts anticipate that Danaher Corporation will post 7.63 EPS for the current year.

Analyst Upgrades and Downgrades

DHR has been the topic of a number of research reports. Jefferies Financial Group reduced their target price on shares of Danaher from $260.00 to $230.00 and set a "buy" rating on the stock in a research report on Tuesday, April 22nd. Robert W. Baird increased their price objective on shares of Danaher from $225.00 to $226.00 and gave the company an "outperform" rating in a report on Friday, July 18th. TD Cowen increased their price objective on shares of Danaher from $240.00 to $248.00 and gave the company a "buy" rating in a report on Wednesday, April 23rd. Deutsche Bank Aktiengesellschaft cut their price objective on shares of Danaher from $240.00 to $235.00 in a report on Thursday, June 5th. Finally, Wall Street Zen upgraded shares of Danaher from a "hold" rating to a "buy" rating in a report on Friday, June 27th. Three equities research analysts have rated the stock with a hold rating and eighteen have assigned a buy rating to the company's stock. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus price target of $247.61.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.